The Extreme Costs Of A Bioburden Incident - Infographic

Source: GE Healthcare Life Sciences
Contact The Supplier

Apart from the potentially tragic impact on patients, the economic consequences of a batch failure are enormous. For the mAb blockbusters, a month production stop can result in lost revenues of up to 1 billion dollars and a typical QA investigation could cost $20,000.  Thankfully, there are solutions for decreasing the risks.  Download this Infographic on the financial impact of a bioburden incident and ways to reduce said impact.